137 related articles for article (PubMed ID: 15598971)
1. Role of breast cancer resistance protein (Bcrp1/Abcg2) in the extrusion of glucuronide and sulfate conjugates from enterocytes to intestinal lumen.
Adachi Y; Suzuki H; Schinkel AH; Sugiyama Y
Mol Pharmacol; 2005 Mar; 67(3):923-8. PubMed ID: 15598971
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer resistance protein (Bcrp1/Abcg2) limits net intestinal uptake of quercetin in rats by facilitating apical efflux of glucuronides.
Sesink AL; Arts IC; de Boer VC; Breedveld P; Schellens JH; Hollman PC; Russel FG
Mol Pharmacol; 2005 Jun; 67(6):1999-2006. PubMed ID: 15749994
[TBL] [Abstract][Full Text] [Related]
3. Impaired renal excretion of 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl) benzothiazole (E3040) sulfate in breast cancer resistance protein (BCRP1/ABCG2) knockout mice.
Mizuno N; Suzuki M; Kusuhara H; Suzuki H; Takeuchi K; Niwa T; Jonker JW; Sugiyama Y
Drug Metab Dispos; 2004 Sep; 32(9):898-901. PubMed ID: 15319327
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability of the glucuronide and sulfate conjugates of genistein and daidzein in breast cancer resistance protein 1 knockout mice.
Álvarez AI; Vallejo F; Barrera B; Merino G; Prieto JG; Tomás-Barberán F; Espín JC
Drug Metab Dispos; 2011 Nov; 39(11):2008-12. PubMed ID: 21828252
[TBL] [Abstract][Full Text] [Related]
5. The important role of Bcrp (Abcg2) in the biliary excretion of sulfate and glucuronide metabolites of acetaminophen, 4-methylumbelliferone, and harmol in mice.
Zamek-Gliszczynski MJ; Nezasa K; Tian X; Kalvass JC; Patel NJ; Raub TJ; Brouwer KL
Mol Pharmacol; 2006 Dec; 70(6):2127-33. PubMed ID: 16959944
[TBL] [Abstract][Full Text] [Related]
6. Kinetic analysis of hepatobiliary transport for conjugated metabolites in the perfused liver of mutant rats (EHBR) with hereditary conjugated hyperbilirubinemia.
Takenaka O; Horie T; Kobayashi K; Suzuki H; Sugiyama Y
Pharm Res; 1995 Nov; 12(11):1746-55. PubMed ID: 8592681
[TBL] [Abstract][Full Text] [Related]
7. Hepatic clearance of reactive glucuronide metabolites of diclofenac in the mouse is dependent on multiple ATP-binding cassette efflux transporters.
Lagas JS; Sparidans RW; Wagenaar E; Beijnen JH; Schinkel AH
Mol Pharmacol; 2010 Apr; 77(4):687-94. PubMed ID: 20086033
[TBL] [Abstract][Full Text] [Related]
8. Involvement of breast cancer resistance protein (BCRP1/ABCG2) in the bioavailability and tissue distribution of trans-resveratrol in knockout mice.
Alfaras I; Pérez M; Juan ME; Merino G; Prieto JG; Planas JM; Alvarez AI
J Agric Food Chem; 2010 Apr; 58(7):4523-8. PubMed ID: 20232796
[TBL] [Abstract][Full Text] [Related]
9. Intestinal breast cancer resistance protein (BCRP)/Bcrp1 and multidrug resistance protein 3 (MRP3)/Mrp3 are involved in the pharmacokinetics of resveratrol.
van de Wetering K; Burkon A; Feddema W; Bot A; de Jonge H; Somoza V; Borst P
Mol Pharmacol; 2009 Apr; 75(4):876-85. PubMed ID: 19114588
[TBL] [Abstract][Full Text] [Related]
10. Different biliary excretion systems for glucuronide and sulfate of a model compound; study using Eisai hyperbilirubinemic rats.
Takenaka O; Horie T; Suzuki H; Sugiyama Y
J Pharmacol Exp Ther; 1995 Sep; 274(3):1362-9. PubMed ID: 7562509
[TBL] [Abstract][Full Text] [Related]
11. Carrier-mediated active transport of the glucuronide and sulfate of 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl) benzothiazole (E3040) into rat liver: quantitative comparison of permeability in isolated hepatocytes, perfused liver and liver in vivo.
Takenaka O; Horie T; Suzuki H; Sugiyama Y
J Pharmacol Exp Ther; 1997 Feb; 280(2):948-58. PubMed ID: 9023311
[TBL] [Abstract][Full Text] [Related]
12. Kinetic analysis of the primary active transport of conjugated metabolites across the bile canalicular membrane: comparative study of S-(2,4-dinitrophenyl)-glutathione and 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)benzothiazole glucuronide.
Niinuma K; Takenaka O; Horie T; Kobayashi K; Kato Y; Suzuki H; Sugiyama Y
J Pharmacol Exp Ther; 1997 Aug; 282(2):866-72. PubMed ID: 9262353
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer resistance protein (ABCG2) determines distribution of genistein phase II metabolites: reevaluation of the roles of ABCG2 in the disposition of genistein.
Yang Z; Zhu W; Gao S; Yin T; Jiang W; Hu M
Drug Metab Dispos; 2012 Oct; 40(10):1883-93. PubMed ID: 22736306
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the role of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated protein 4 (MRP4/ABCC4) in the urinary excretion of sulfate and glucuronide metabolites of edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one).
Mizuno N; Takahashi T; Kusuhara H; Schuetz JD; Niwa T; Sugiyama Y
Drug Metab Dispos; 2007 Nov; 35(11):2045-52. PubMed ID: 17682070
[TBL] [Abstract][Full Text] [Related]
15. Regional expression and activity of breast cancer resistance protein (Bcrp/Abcg2) in mouse intestine: overlapping distribution with sulfotransferases.
Enokizono J; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2007 Jun; 35(6):922-8. PubMed ID: 17353350
[TBL] [Abstract][Full Text] [Related]
16. Breast Cancer Resistance Protein and Multidrug Resistance Protein 2 Determine the Disposition of Esculetin-7-O-Glucuronide and 4-Methylesculetin-7-O-Glucuronide.
Li Y; Song W; Ou X; Luo G; Xie Y; Sun R; Wang Y; Qi X; Hu M; Liu Z; Zhu L
Drug Metab Dispos; 2019 Mar; 47(3):203-214. PubMed ID: 30602435
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of intestinal absorption of amtolmetin guacyl in rats: breast cancer resistant protein as a primary barrier of oral bioavailability.
Rong Z; Xu Y; Zhang C; Xiang D; Li X; Liu D
Life Sci; 2013 Feb; 92(3):245-51. PubMed ID: 23333829
[TBL] [Abstract][Full Text] [Related]
18. The gut microbiota ellagic acid-derived metabolite urolithin A and its sulfate conjugate are substrates for the drug efflux transporter breast cancer resistance protein (ABCG2/BCRP).
González-Sarrías A; Miguel V; Merino G; Lucas R; Morales JC; Tomás-Barberán F; Alvarez AI; Espín JC
J Agric Food Chem; 2013 May; 61(18):4352-9. PubMed ID: 23586460
[TBL] [Abstract][Full Text] [Related]
19. Identification of the transporters involved in the hepatobiliary transport and intestinal efflux of methyl 1-(3,4-dimethoxyphenyl)-3-(3-ethylvaleryl)-4-hydroxy-6,7,8-trimethoxy-2-naphthoate (S-8921) glucuronide, a pharmacologically active metabolite of S-8921.
Sakamoto S; Kusuhara H; Horie K; Takahashi K; Baba T; Ishizaki J; Sugiyama Y
Drug Metab Dispos; 2008 Aug; 36(8):1553-61. PubMed ID: 18474677
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the role of multidrug resistance-associated protein (Mrp) 3 and Mrp4 in hepatic basolateral excretion of sulfate and glucuronide metabolites of acetaminophen, 4-methylumbelliferone, and harmol in Abcc3-/- and Abcc4-/- mice.
Zamek-Gliszczynski MJ; Nezasa K; Tian X; Bridges AS; Lee K; Belinsky MG; Kruh GD; Brouwer KL
J Pharmacol Exp Ther; 2006 Dec; 319(3):1485-91. PubMed ID: 16988054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
